Piscataway, NJ, United States of America

Siva Ram Kiran Vaka

This inventor holds 32 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Amneal Complex Products Research LLC, Kashiv Biosciences, LLC, Kashiv Specialty Pharmaceuticals, LLC. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Siva Ram Kiran Vaka. Retrieved from https://idiyas.com/inventor/siva-ram-kiran-vaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 32 

% Patents Active = 96.9

 

 

Average Co-Inventor Count = 5.9

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Delayed Release Compositions
Extended Release Compositions
Gastroretentive Dosage Forms
Programmable Pharmaceutical Compositions
Abuse-Resistant Drug Formulations
Chrono Drug Release
Opioid Agonist
Trihexyphenidyl
Pyridostigmine
Methylphenidate
Self-Nanoemulsion
Fine Particles Manufacturing
32 patents (USPTO):Explore Patents

Title: Innovations by Siva Ram Kiran Vaka: Pioneering Drug Delivery Systems

Introduction

Siva Ram Kiran Vaka is an accomplished inventor based in Piscataway, NJ, known for his extensive contributions to pharmaceutical innovations. With a remarkable portfolio of 31 patents, Vaka has dedicated his research efforts toward developing advanced drug delivery systems that enhance patient compliance and therapeutic effectiveness.

Latest Patents

Among his latest patents are innovative formulations like the extended release compositions comprising pyridostigmine. These novel dosage forms are designed to maintain stable plasma concentrations while minimizing initial burst release or dose dumping. The inventions encompass matrix tablets, gastroretentive tablets, and pellets suitable for various dosing methods, including incorporation into foodstuffs. Another significant patent involves gastroretentive dosage forms aimed at prolonged gastric residence time. This technology comprises rapidly expanding systems that allow targeted drug release in the proximal gastrointestinal tract, optimizing therapeutic outcomes. These innovative drug delivery systems are pivotal in improving patient adherence to medication regimens.

Career Highlights

Siva Ram Kiran Vaka has made significant strides in the pharmaceutical industry, working with leading companies such as Amneal Complex Products Research and Kashiv Biosciences. His role at these organizations has been instrumental in the development of next-generation drug formulations, reinforcing his reputation as a leading inventor in the field of pharmaceutical sciences.

Collaborations

Throughout his career, Vaka has collaborated with talented professionals including Dipen Desai and Wantanee Phuapradit. These partnerships underscore the importance of teamwork in driving innovation and advancing the frontiers of pharmaceutical technology.

Conclusion

With a focus on enhancing drug delivery systems, Siva Ram Kiran Vaka continues to make impactful contributions to the field of pharmaceuticals. His extensive patent portfolio and collaborations reflect a strong commitment to improving patient care and therapeutic efficacy through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…